[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D011897:Random Allocation; D013468:Suloctidil / Q000627:therapeutic use*; D013806:Theophylline / Q000031:analogs & derivatives*; D013997:Time Factors; D014971:Xanthinol Niacinate / Q000627:therapeutic use*
D011412:Propanolamines; D014971:Xanthinol Niacinate; D013806:Theophylline; D013468:Suloctidil
La terapia medica dell'arteriopatia ostruttiva cronica degli arti inferiori. Studio clinico controllato suloctidil versus xantinolo.